| Financial Year |
March 31 2023 |
| Monetary Funds |
1,429,733,808.80 |
| Held-for-trading Financial Assets |
826,564,639.52 |
| Notes Receivable |
25,771,245.44 |
| Accounts Receivable |
765,635,440.37 |
| Advances to Suppliers |
68,792,086.54 |
| Other Receivables |
38,754,459.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,241,618,636.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
314,157,500.00 |
| Other Current Assets |
69,839,768.49 |
| Total Current Assets |
4,853,149,602.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
964,299.00 |
| Long-term Equity Investment |
93,752,046.01 |
| Investment Properties |
-- |
| Fixed Assetes |
565,867,646.04 |
| Under-construction Projects |
71,640,546.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
363,731,709.22 |
| R&D expenses |
3,702,229.76 |
| Goodwill |
432,511,475.32 |
| Long-Term Deferred and Prepaid Expenses |
18,420,319.96 |
| Deferred Income Tax Assets |
247,119,485.63 |
| Other Non-Current Assets |
57,827,610.24 |
| Sub-Total of Non-Current Assets |
2,274,638,355.41 |
| Total Assets |
7,127,787,958.35 |
| Short-Term Loans |
96,301,680.12 |
| Trading Financial liabilities |
57,027,528.33 |
| Notes Payable |
130,127,953.80 |
| Accounts Payable |
703,414,660.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
126,518,352.61 |
| Taxes Payable |
34,356,429.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
114,071,613.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
320,259,921.59 |
| Other Current Liabilities |
7,843,151.62 |
| Sub-Total of Current Liabilities |
2,415,036,066.95 |
| Long-term Loans |
56,452,115.15 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
118,690,395.19 |
| Deferred Income Tax Liabilities |
5,463,483.83 |
| Other Non-Current Liabilities |
136,603,881.90 |
| Sub-Total of Non-Current Liabilities |
402,428,741.25 |
| Total Liabilities |
2,817,464,808.20 |
| Paid-In Capital(Or Share Stock) |
1,240,978,400.00 |
| Capital Surplus |
2,954,305,867.27 |
| Surplus Reserve |
51,830,974.45 |
| LESS:Treasury Stock |
309,451,578.83 |
| Undistributed Profits |
107,992,065.03 |
| Minority Stockholder's Interest |
213,457,536.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,096,865,613.57 |
| Owner's Equity（Stockholder's Equity） |
4,310,323,150.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,127,787,958.35 |
